Cycle totals
discovered 24 ·
inserted 16 ·
enriched 1 ·
generated 1 ·
posted 0
1. Collection
19 unique videos discovered
leaders 19
article search 5
thought leader (19 sampled, 19 total)
Are backyard chickens actually worth the money, time, and hassle? After eight months of managing a mixed flock—from hatching eggs with a broody hen to managing the "deep litter" method—I’m breaking down the raw numbers and the reality of ho
Inside an HNW cybercrime arbitration: nine phases from filing to a confirmed award — explained by the attorney who has done it 130+ times.
For high-net-worth families, family offices, and founders, the most consequential financial disputes
📹 Watch the DialBenjy podcast, NEW episode every week!
Why? Whether you're an employee, a business owner, or just someone who wants to stay informed, this channel is the perfect place to stay up-to-date on legal matters that affect you.
The circumstances surrounding the death of Jeffrey Epstein remain a constant topic of public discussion and skepticism. Many people continue to debate the details of the 2019 incident and the horrific history of abuse involving hundreds of
Urban ER vs. Rural ER
Most investment fraud cases reach us through a client's trusted advisors. Lawyers, accountants, and financial professionals see the account statements, the tax returns, the warning signs, often before anyone else does. For elderly clients o
Thanks for watching! In this video I finished the 1300 miles to Joplin, where the start of Pole Barn Garage’s Poverty Tour kicks off touring Route 66! I fixed the driveshaft from the last video with a new u-joint and hit the road. Hope you
Thanks for watching! In this video I make it from the east coast of New Jersey all the way west of Indianapolis, where I have my first break down and then some! Hope you enjoy the video
Thanks for watching! In today’s video I thrash to get as much done on the camper before I begin my trek from New Jersey to Missouri to start Pole Barn Garage’s poverty tour! I finish the plumbing, add in my bed, my refrigerator, countertops
Exploring the legal boundaries of artificial intelligence. Discover potential lawsuits against AI giants like OpenAI and the evolving legal landscape for AI companies. #AILaw #TechLegal #OpenAI #ArtificialIntelligence
Florida's Attorney General probes OpenAI, equating AI's role to aiding murder. Meanwhile, a legal shift reclassifies AI like ChatGPT from websites to products, paving the way for product liability lawsuits. #OpenAI #AIInvestigation #Product
OpenAI and other AI giants face lawsuits claiming they are manufacturers of defective products. This challenges Section 230, which has long shielded online platforms. #AISued #Section230 #TechLaw #ArtificialIntelligence
Served with a lawsuit? HUGE mistake to contact the opposing party directly. Beware the 'goodwill trap'! All communication MUST go through your attorney to protect your rights. #LegalTips #Lawsuit #DontTalkToThem #AttorneyAdvice
Facing a lawsuit in Florida? This video breaks down critical steps you must take immediately after being served. Learn the essential actions and avoid a costly mistake. #FloridaLaw #Lawsuit #LegalTips #KnowYourRights
Are backyard chickens actually worth the money, time, and hassle? After eight months of managing a mixed flock—from hatching eggs with a broody hen to managing the "deep litter" method—I’m breaking down the raw numbers and the reality of ho
Inside an HNW cybercrime arbitration: nine phases from filing to a confirmed award — explained by the attorney who has done it 130+ times.
For high-net-worth families, family offices, and founders, the most consequential financial disputes
📹 Watch the DialBenjy podcast, NEW episode every week!
Why? Whether you're an employee, a business owner, or just someone who wants to stay informed, this channel is the perfect place to stay up-to-date on legal matters that affect you.
The circumstances surrounding the death of Jeffrey Epstein remain a constant topic of public discussion and skepticism. Many people continue to debate the details of the 2019 incident and the horrific history of abuse involving hundreds of
Urban ER vs. Rural ER
article search (5 sampled, 5 total)
Retatrutide pode ser a próxima grande etapa no tratamento medicamentoso da obesidade. Depois do Ozempic, que atua no GLP-1, e do Mounjaro, que atua em GLP-1 e GIP, surge uma nova molécula que adiciona um terceiro alvo: o receptor de glucago
Сегодня мы рассмотри класс препаратов для похудения - семаглутид (оземпик), тирзепатид и ретатрутид. Видео является информативным и не призывает вас к действиям.
0:00 Введение
0:22 Дисклаймер
0:35 Проверка здоровья до приема препаратов
1:3
Most people who come off GLP-1s gain the weight back. Not because the medication failed, but because of what they did or didn't do while they were on it. Here's exactly what separates the people who keep it off from the ones who rebound com
Most people assume that once you hit your goal weight on a GLP-1 medicine, you just stop taking it and move on. Two brand new randomized controlled trials say that is not how this works for most people.
Dr. Spencer and Dr. Karl break down
Dave Knapp from On The Pen breaks down EVERY major obesity drug that has completed a Phase 3 clinical trial, including Retatrutide, Zepboound, CagriSema, Orforglipron, high dose Wegovy, Mazdutide, Rebupatide, Servodutide, and more.
If you
2. Hard filter (Shorts / live / view count)
passed 24 · dropped 269
Low views (<200) 217Short / under min duration 39Live / upcoming 13
Show 50 dropped videos
Craving, Impulsivity, and Subsequent Methamphetamine Use With Naltrexone-Bupropion Versus Placebo...
Low views (<200)
In this episode of Beyond The Abstract, Dr. Manish Jha stops by to talk about his new article Craving, Impulsivity, and Subsequent Methamphetamine Use With Naltrexone-Bupropion Versus Placebo: Findings From a Randomized Clinical Trial featu
Lead: Methamphetamine use among adult patients presenting with acute coronary syndrome: A single‐...
Low views (<200)
Methamphetamine use among adult patients presenting with acute coronary syndrome: A single‐center retrospective cohort study (https://email.asam.org/t/t-i-whyudty-l-o/) 🔓
Journal of the American Heart Association
This study included 1
Low views (<200)
Pharmacist Ben Fuchs:
Why Do You Think You Can’t Take Your Nutrients With Your Medication? DWD 5/28/26
https://dailywithdocteam.com/
https://triangleofdisease.com/
Please email Questions@dailywithdoc.com OR CALL 855-949.3377
Good Foods
Low views (<200)
RICK HEATH
TrūAura - Ramping Up Your Skin Game With Probiotic Use Beyond The Gut. DWD 5/28/26
Guest Rick Heath From TrūAura, As He Shares With Us How The TrūAura Line Of Products Where Specifically Designed With Clean Ingredients To Suppor
Low views (<200)
Pharmacist Ben: Let's help folks with Parkinson's ! PBB 5/25/26
Pharmacist Ben Fuchs R, PH. will be discussing:
Research States that vitamins could potentially help with Parkinson's disease. Hear the debate!
So tune in!!!!
https://tria
Low views (<200)
*Transcript:* Tips for Preparing a Responsive Letter of Intent, or LOI.
PCORI is an important part of the country’s research enterprise, and people are increasingly turning to PCORI for funding for patient-centered comparative clinical eff
Low views (<200)
In this video, Tsuyoshi Kaneko, MD, vice chair, STS Council on Education, furthers the discussion regarding the growing importance of long-term evidence in the management of aortic valve disease. He examines new data comparing TAVI and SAVR
Low views (<200)
Michael Bowdish, MD, chair, STS Workforce on Adult Cardiac Surgery Database, highlights how evolving evidence is reshaping decision-making in aortic valve disease. He provides an overview of transcatheter aortic valve implantation (TAVI) an
Low views (<200)
STS President Vinay Badhwar, MD, shares the latest efforts advancing evidence-based, patient-centered care—from national advocacy for early lung cancer detection to support for the multidisciplinary heart team model and continued investment
Low views (<200)
In recognition of National Women’s Health Month, this episode of Thinking Thoracic analyzes the evolving landscape of female-specific lung cancer care. Co-hosts Dr. Erin Gillaspie and Dr. Jane Yanagawa sit down with guest Dr. Leah Backhus t
Low views (<200)
A diverse panel of surgeons from Latin America and the United States will discuss the current guidelines for the surgical management of left main stem, medical and interventional treatments, and surgical techniques.
This session is a collab
Low views (<200)
The first congenital webinar in our STS South Asia webinar series delves into the topic of pulmonary vein stenosis in TAPVC. Expert surgeons from both the United States and South Asia will speak on both the primary and secondary pathologies
Shifting our health system from treating sickness to prioritizing prevention doesn't happenovernight
Low views (<200)
Dr. J. Nadine Gracia is joined by Dr. Jeff Levi, TFAH’s former Executive Director, and Rich Hamburg, TFAH’s former Executive Vice President and COO/Former Interim President and CEO, to reflect on TFAH’s pivotal role during the passage and i
Ready or Not 2026 Protecting the Public's Health from Diseases, Disasters, and Bioterrorism Briefing
Low views (<200)
TFAH's media briefing on the Ready or Not 2026: Protecting the Public's Health from Diseases, Disasters, and Bioterrorism report. Dr. J. Nadine Gracia, Trust for America's Health President and CEO and Jennifer Nuzzo, Director, Pandemic Cent
Low views (<200)
What if the reason so many of us feel exhausted, disconnected, and unfulfilled isn’t because we’re failing… but because we’ve been taught to live in the wrong mindset entirely? In this conversation, I sat down with Stanford professors and D
Low views (<200)
Richard Pops has lived the biotech roller coaster over three decades as CEO of Alkermes: an IPO, M&A, near-death events for his company, FDA setbacks, battles with an activist investor, and the satisfaction of knowing that millions of patie
Low views (<200)
Richard Pops has lived the biotech roller coaster over three decades as CEO of Alkermes: an IPO, M&A, near-death events for his company, FDA setbacks, battles with an activist investor, and the satisfaction of knowing that millions of patie
Low views (<200)
At ASCO among presentations focused on pancreatic cancer innovation beyond KRAS; however, abstracts for the cancer conference also highlight ADCs, bispecifics and diagnostics that are broadening the field’s approach to the cancer. On the la
Low views (<200)
Cells continuously sense their environment and in response to stressors, adapt, recover, or die. Soley Therapeutics uses its AI platform to capture thousands of intracellular features and map how cells sense, interpret, and respond to stres
Low views (<200)
In this AGD Podcast Series interview, host George Schmidt, DMD, FAGD, interviews ArNelle Wright, DDS, a general dentist and practice owner, where they discuss her journey in dentistry. Dr. Wright shared her transition from being an associat
Low views (<200)
GLP-1 medications seemed to appear overnight: suddenly everywhere from physicians’ offices to TikTok feeds to dinner table conversations. But for obesity and lifestyle medicine specialist Dr. Janelle Duah, the story started long before the
Low views (<200)
On this episode of HL Shorts, we hear from Melanie Heuston, CNE at WVU Medicine and HealthLeaders Exchange member, about the Center for Nursing Education and how addressing social determinants of health and lowering barriers to entry and ma
Kidney Function Decline in Sickle Cell Disease: Associations with Renin Angiotensin System Inhibi...
Low views (<200)
Sickle cell disease causes accelerated kidney function decline, yet proven GFR-preserving therapies remain elusive. In this study of adults with sickle cell disease, RASi use was not associated with a significant difference in the rate of e
Short / under min duration
ASN brings together clinicians, educators, researchers, and trainees in a community that supports connection, mentorship, and collaboration across nephrology. ASN membership helps members grow professionally, build lasting relationships, an
Low views (<200)
Watch the keynote from Samir Parikh, MD, FASN, President of the American Society of Nephrology (ASN), highlighting the impact of the Kidney Health Initiative (KHI) and its role in advancing innovation, regulatory pathways, and patient-cente
Low views (<200)
Anais Taylor, DO, is a board-certified primary care provider serving patients in the Denver metro area. Her clinical interests span a wide range of family medicine services, including Osteopathic Manipulative Treatment (OMT) for conditions
Low views (<200)
Meet Elizabeth Vogel, PA-C, a physician assistant specializing in urogynecology. She is passionate about helping patients address pelvic health concerns, restore confidence, and return to the activities they love. Elizabeth values the posit
Low views (<200)
Meet Dr. Andrew Crandall, an OB/GYN dedicated to caring for women and their newborns every step of the way. He considers it a sacred privilege to be part of a patient’s labor experience and strives to create a comfortable, supportive enviro
Low views (<200)
Meet Haley Pledger, a compassionate women’s health nurse practitioner dedicated to educating women about their bodies at every stage of life. She takes the time to truly understand each patient and how they’re feeling, working collaborative
Low views (<200)
Health care leaders are navigating one of the most volatile policy environments in decades. The next major reform fight hasn’t arrived yet — but in its place, a steady wave of rulemaking, regulatory shifts, and enforcement actions is drivin
Low views (<200)
Watch our informative session Coffee and Taxes: What You Need to Know about Charitable Giving. American Liver Foundation National Board Member and expert on tax, estate and trust planning, Richard Miller, Jr, Esq., provided an engaging over
Low views (<200)
This session offers a focused, research-driven overview of metabolic dysfunction–associated steatotic liver disease (MASLD) in rural populations, tailored for providers in the primary care setting. It will examine current evidence on screen
Low views (<200)
How do healthcare organisations successfully implement AI without falling into the trap of chasing technology for technology’s sake? 🤖🏥
In this episode 589, the discussion explores a disciplined and strategic approach to healthcare innovat
Low views (<200)
In this episode of Talking HealthTech, Peter Birch sits down with Dan Burke, Managing Director at Magentus, and Ben Richardson, CEO at Labflow, for a wide-ranging conversation about the state of pathology in Australia and the broader Asia-P
Low views (<200)
“People aren’t getting healthier. We’re living longer, but not living better.”
Steve Lewis, founder and CEO of Nabu AI, discusses why the biggest and most expensive problem in healthcare is patient adherence, and how digital tools can keep
Low views (<200)
In this episode of Talking HealthTech, Peter Birch speaks with Paula Stephenson (Executive Director of Clinical Excellence, Mercy Health), Bianca Todd (Improvement Innovation Advisor, Western District Health Service), The Hon. Victor Domine
Low views (<200)
"AI is enlightening, but also intimidating to people, so they're looking for answers." 🤖
During the Connected Health & Care Summit Asia-Pacific 2026 hosted by RLDatix APAC, CEO of RLDatix Dan Michelson shares his insights on the fast-chang
Low views (<200)
“Your workforce is your engine – it's 70% of your cost and probably 90% of your opportunity.” 🚀
Hear from Brad Kearns, CEO of Find a Carer, as he share insights with Peter Birch on reshaping workforce management in aged care, from tech-ena
Low views (<200)
"After COVID, we embraced flexibility, but have we forgotten the power of being together in person?" 🤝
During the Connected Health & Care Summit Asia-Pacific 2026 hosted by RLDatix APAC, Nicki Dexter who is the Chief People Officer at RLDa
Low views (<200)
“If we put the patient at the centre of the hub and then put the spokes around the patient, that's the evolutionary thinking that we need.” 🧑⚕️
The Hon. Victor Dominello, CEO of the Future Government Institute and former NSW Minister for
Low views (<200)
“No two of these projects are the same.”
Steve Brewer, Head of Data Solutions at RLDatix, joins Peter Birch during the Connected Health & Care Summit Asia-Pacific 2026 hosted by RLDatix APAC. They discuss the complex challenges of moving v
Low views (<200)
“I just cannot see a future where you're still running servers in hospital basements.” 💻🏥
During the Connected Health & Care Summit Asia-Pacific 2026 hosted by RLDatix APAC, Bettina McMahon - CEO of Healthdirect Australia, discusses the mo
Low views (<200)
Why are women emergency physicians facing a "bimodal drop-off" in their 30s and 40s — and how can building a well workplace for women create a better environment for all human beings?
In this episode, Dr. Laurel Barr sits down with Dr. And
Low views (<200)
What does it look like to treat the underlying chronic disease of addiction from the front lines of the ED — and how are new non-opioid alternatives reshaping pain management?
In this episode, Dr. Laurel Barr sits down with Dr. Ruben Stray
Low views (<200)
Recorded live at the ACEP Leadership and Advocacy Conference, this episode of ACEP Frontline features a timely conversation with Dr. Sean Michael, Chief Medical Officer for Centers for Medicare & Medicaid Services. As emergency departments
Low views (<200)
Brain fog in perimenopause is real — and it's more than just "getting older." In this video, Dr. Blake explains why your brain is so sensitive to hormonal fluctuations during midlife, what estrogen actually does for cognition and energy, an
Low views (<200)
Speakers:
- Fer Tornos, PhD, EMEA NGS Field Application Support Manager, Twist Bioscience, Europe
- Dr. Gerald Martin B.A.(Hons), PhD, Commercial Applications Scientist, OncoDNA, Belgium
- Dr. Beatriz Bellosillo, Head Molecular Diagnostic
Low views (<200)
Enterprises are moving fast on AI—but scaling it beyond pilots remains a challenge. In this video, leaders from Dell Technologies and Cognizant share how to operationalize AI through a secure, scalable, and integrated foundation—bringing to
Short / under min duration
Leave with evidence, not stalled pilots.
Low views (<200)
In Physical AI, the goal isn’t just speed. It’s certainty: seeing where challenges occur, making crucial improvements, and leaving with evidence and a clear path to scale.
What matters is knowing how systems behave under pressure—before t
3. Queue dedup & per-channel cap
inserted 16 · skipped 8
Already in queue 8
Show 8 skipped videos
Already in queue
Are backyard chickens actually worth the money, time, and hassle? After eight months of managing a mixed flock—from hatching eggs with a broody hen to managing the "deep litter" method—I’m breaking down the raw numbers and the reality of ho
Already in queue
Inside an HNW cybercrime arbitration: nine phases from filing to a confirmed award — explained by the attorney who has done it 130+ times.
For high-net-worth families, family offices, and founders, the most consequential financial disputes
Already in queue
📹 Watch the DialBenjy podcast, NEW episode every week!
Why? Whether you're an employee, a business owner, or just someone who wants to stay informed, this channel is the perfect place to stay up-to-date on legal matters that affect you.
Already in queue
The circumstances surrounding the death of Jeffrey Epstein remain a constant topic of public discussion and skepticism. Many people continue to debate the details of the 2019 incident and the horrific history of abuse involving hundreds of
Already in queue
Сегодня мы рассмотри класс препаратов для похудения - семаглутид (оземпик), тирзепатид и ретатрутид. Видео является информативным и не призывает вас к действиям.
0:00 Введение
0:22 Дисклаймер
0:35 Проверка здоровья до приема препаратов
1:3
Already in queue
Most people who come off GLP-1s gain the weight back. Not because the medication failed, but because of what they did or didn't do while they were on it. Here's exactly what separates the people who keep it off from the ones who rebound com
Already in queue
Dave Knapp from On The Pen breaks down EVERY major obesity drug that has completed a Phase 3 clinical trial, including Retatrutide, Zepboound, CagriSema, Orforglipron, high dose Wegovy, Mazdutide, Rebupatide, Servodutide, and more.
If you
4. Claude matching (threshold 45)
evaluated 2 ·
cache-skipped 14 ·
queued 1
No match: 1
Queued: 1
Queued (1)
Sue OpenAI? AI's Legal Shield is CRACKING! #shorts
confidence 62
→ Nobody gets sued but the doctor: The legal vacuum at the center of the AI physician revolution
Exploring the legal boundaries of artificial intelligence. Discover potential lawsuits against AI giants like OpenAI and the evolving legal landscape for AI companies. #AILaw #TechLegal #OpenAI #ArtificialIntelligence
No match returned (1 sampled)
Road to Poverty Tour 2026! NJ TO MO! Part 1
Claude returned no match (off-topic)
Thanks for watching! In this video I make it from the east coast of New Jersey all the way west of Indianapolis, where I have my first break down and then some! Hope you enjoy the video
Cache-skipped (14 sampled — already evaluated within cooldown)
8 Months With Backyard Chickens: Was It Worth It?
Already evaluated within cooldown
Are backyard chickens actually worth the money, time, and hassle? After eight months of managing a mixed flock—from hatching eggs with a broody hen to managing the "deep litter" method—I’m breaking down the raw numbers and the reality of ho
Inside an HNW Cybercrime Arbitration: From Filing to Award
Already evaluated within cooldown
Inside an HNW cybercrime arbitration: nine phases from filing to a confirmed award — explained by the attorney who has done it 130+ times.
For high-net-worth families, family offices, and founders, the most consequential financial disputes
Can your employer change your job responsibilities or lower your salary without your consent?
Already evaluated within cooldown
📹 Watch the DialBenjy podcast, NEW episode every week!
Why? Whether you're an employee, a business owner, or just someone who wants to stay informed, this channel is the perfect place to stay up-to-date on legal matters that affect you.
Unpacking The Accountability Of Epstein Files
Already evaluated within cooldown
The circumstances surrounding the death of Jeffrey Epstein remain a constant topic of public discussion and skepticism. Many people continue to debate the details of the 2019 incident and the horrific history of abuse involving hundreds of
Urban ER vs. Rural ER #shorts
Already evaluated within cooldown
Urban ER vs. Rural ER
How Lawyers & Accountants Help Catch Investment Fraud
Already evaluated within cooldown
Most investment fraud cases reach us through a client's trusted advisors. Lawyers, accountants, and financial professionals see the account statements, the tax returns, the warning signs, often before anyone else does. For elderly clients o
Making it to Joplin! Road to Poverty Tour part 2!
Already evaluated within cooldown
Thanks for watching! In this video I finished the 1300 miles to Joplin, where the start of Pole Barn Garage’s Poverty Tour kicks off touring Route 66! I fixed the driveshaft from the last video with a new u-joint and hit the road. Hope you
Pre-Poverty Tour Thrash! 1949 camper build part 2
Already evaluated within cooldown
Thanks for watching! In today’s video I thrash to get as much done on the camper before I begin my trek from New Jersey to Missouri to start Pole Barn Garage’s poverty tour! I finish the plumbing, add in my bed, my refrigerator, countertops
OpenAI Faces Murder Charge Investigation: Is AI a Product? #OpenAI #AIinvestigation
Already evaluated within cooldown
Florida's Attorney General probes OpenAI, equating AI's role to aiding murder. Meanwhile, a legal shift reclassifies AI like ChatGPT from websites to products, paving the way for product liability lawsuits. #OpenAI #AIInvestigation #Product
Section 230: AI Lawsuits & The End of Tech Immunity? #AISued #Section230 #TechLaw
Already evaluated within cooldown
OpenAI and other AI giants face lawsuits claiming they are manufacturers of defective products. This challenges Section 230, which has long shielded online platforms. #AISued #Section230 #TechLaw #ArtificialIntelligence
Don't Call Them! The Goodwill Trap After Being Served #shorts
Already evaluated within cooldown
Served with a lawsuit? HUGE mistake to contact the opposing party directly. Beware the 'goodwill trap'! All communication MUST go through your attorney to protect your rights. #LegalTips #Lawsuit #DontTalkToThem #AttorneyAdvice
Sued in Florida? 5 Moves to Win, 1 Mistake to Avoid! #shorts
Already evaluated within cooldown
Facing a lawsuit in Florida? This video breaks down critical steps you must take immediately after being served. Learn the essential actions and avoid a costly mistake. #FloridaLaw #Lawsuit #LegalTips #KnowYourRights
COMO O RETATRUTIDE PODE SUPERAR O MOUNJARO NO EMAGRECIMENTO?
Already evaluated within cooldown
Retatrutide pode ser a próxima grande etapa no tratamento medicamentoso da obesidade. Depois do Ozempic, que atua no GLP-1, e do Mounjaro, que atua em GLP-1 e GIP, surge uma nova molécula que adiciona um terceiro alvo: o receptor de glucago
The Truth About GLP-1 Maintenance No One is Talking About | Docs Who Lifts
Already evaluated within cooldown
Most people assume that once you hit your goal weight on a GLP-1 medicine, you just stop taking it and move on. Two brand new randomized controlled trials say that is not how this works for most people.
Dr. Spencer and Dr. Karl break down